Ublituximab for treating relapsing multiple sclerosis: A Cost Comparison Evaluation

Research output: Book/Report › Commissioned report

Original language	English
Publisher	National Institute for Health and Care Excellence
Commissioning body	National Institute for Health and Care Excellence
Publication status	Published - 29 Nov 2024

Access to Document

@book{040416d3ca3041b6b4f9ee7e1f607dec,

title = "Ublituximab for treating relapsing multiple sclerosis: A Cost Comparison Evaluation",

author = "Anqian Zhou and Noortje Uphoff and Corbett, {Mark Stephen} and Helen Fulbright and Claire Rothery and Simmonds, {Mark Crawford}",

year = "2024",

month = nov,

day = "29",

language = "English",

publisher = "National Institute for Health and Care Excellence",

}

TY - BOOK

T1 - Ublituximab for treating relapsing multiple sclerosis

T2 - A Cost Comparison Evaluation

AU - Zhou, Anqian

AU - Uphoff, Noortje

AU - Corbett, Mark Stephen

AU - Fulbright, Helen

AU - Rothery, Claire

AU - Simmonds, Mark Crawford

PY - 2024/11/29

Y1 - 2024/11/29

M3 - Commissioned report

BT - Ublituximab for treating relapsing multiple sclerosis

PB - National Institute for Health and Care Excellence

ER -